
GBS GBS
Quarterly report 2025-Q4
added 02-12-2026
Country |
|
IPO year |
2020 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
5.27 M |
Market Cap[1] |
$ 7.12 M |
EBITDA (LTM) |
$ -9.31 M |
P/E (LTM) |
- |
P/S (LTM) |
2.02 |
EPS (LTM) |
-8.57 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
FONAR Corporation
FONR
|
$ 18.58 | -0.11 % | $ 122 M | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.0 | -0.58 % | $ 1.62 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Globus Medical
GMED
|
$ 90.43 | 2.07 % | $ 12.2 B | NYSE,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 9.11 | -2.88 % | $ 258 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 36.38 | -0.98 % | $ 5.42 K | Nasdaq Global Select Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 1.8 | -5.53 % | $ 1.09 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.25 | -0.64 % | $ 712 M | Nasdaq Global Select Market,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 54.48 | 0.63 % | $ 1.6 B | NYSE,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.03 | 3.35 % | $ 17.4 M | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.52 | -0.13 % | $ 2.97 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
LENSAR
LNSR
|
$ 5.77 | -2.04 % | $ 69 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.82 | -0.75 % | $ 371 M | Nasdaq Global Select Market,SPB | ||
|
Medtronic PLC
MDT
|
$ 86.33 | 0.06 % | $ 111 B | NYSE,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.42 | -1.16 % | $ 128 M | Nasdaq Global Market | ||
|
Myomo
MYO
|
$ 0.67 | -4.85 % | $ 28 M | NYSE American | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 168.21 | -2.13 % | $ 12.6 B | Nasdaq Global Select Market,SPB | ||
|
Orthofix Medical
OFIX
|
$ 11.81 | 0.34 % | $ 468 M | Nasdaq Global Select Market,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 31.01 | -4.99 % | $ 1.43 B | Nasdaq Capital Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Insulet Corporation
PODD
|
$ 204.23 | 0.36 % | $ 14.4 B | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 2.76 | 9.09 % | $ 7.65 M | Nasdaq Capital Market | ||
|
Smith & Nephew plc
SNN
|
$ 31.76 | -2.67 % | $ 23.8 B | NYSE | ||
|
Butterfly Network
BFLY
|
$ 4.02 | -2.66 % | $ 851 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Stryker Corporation
SYK
|
$ 331.18 | -0.34 % | $ 127 B | NYSE,SPB | ||
|
Tactile Systems Technology
TCMD
|
$ 24.16 | -1.67 % | $ 553 M | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | 3.37 % | $ 38 M | Nasdaq Capital Market | ||
|
TELA Bio
TELA
|
$ 0.7 | 11.11 % | $ 32.9 M | Nasdaq Global Select Market | ||
|
TransMedics Group
TMDX
|
$ 107.91 | 2.97 % | $ 3.67 B | Nasdaq Global Market | ||
|
Tandem Diabetes Care
TNDM
|
$ 18.66 | -2.66 % | $ 1.27 B | Nasdaq Global Market,SPB | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 9.68 | -0.21 % | $ 347 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 61.33 | -2.01 % | $ 90.8 B | NYSE,SPB | ||
|
Alphatec Holdings
ATEC
|
$ 11.09 | 1.05 % | $ 1.66 B | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.